Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
High-sensitivity Troponin in Cardiac Surgery
Author(s): Cuilin Zhu , Xiaomeng Wang , Xiao Liu , et al Added: 3 months ago

MI/ACS
Lipoprotein(a) May be Falsely Lowered When Troponin T is Elevated
Author(s): Colin Yeo , Xuan Han Koh , Weien Chow , et al Added: 12 months ago

MI/ACS

Prevention & Chronic Conditions
Troponin Level and Revascularisation Likelihood in T2MI
Author(s): Rachael Hii , Mau T Nguyen , Kristina Lambrakis , et al Added: 8 months ago

MI/ACS
Undetectable hs-TnI Serves as a De-risking Marker
Author(s): Phattararuethai Sabkaewyod , Prin Vathesatogkit , Piyamitr Sritara Added: 1 year ago

Prevention & Chronic Conditions
Implementing AI Algorithms in Emergency Departments: RAPIDxAI with Dr Chew
Author(s): Dipti Itchhaporia , Derek P Chew Added: 1 year ago
Host, Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute, Newport Beach, CA, US) is joined by PI, Dr Derek Chew (Monash Heart and Victorian Heart Institute, AU) to discuss the findings from the RAPIDxAI trial, which aims to improve the assessment of suspected cardiac chest pain in emergency departments (ED) using a machine-learning algorithm that will interpret high-sensitivity troponin test… View more

Digital Health
ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT
Author(s): David Austin Added: 2 years ago
ACC.24 — We are joined onsite by Dr David Austin (South Tees Hospitals NHS Foundation Trust, UK) to discuss the findings from the PROACT trial (NCT03265574).Anthracyclines used in the treatment of breast cancer cause damage to the muscle cells in the heart, resulting in cardiotoxicity.PROACT is a phase III randomised superiority trial of enalapril for the prevention of anthracycline-induced… View more

CV Disease in Special Populations
ESC 23: ARAMIS: Anakinra versus Placebo in Acute Myocarditis
Author(s): Gilles Montalescot , Mathieu Kerneis Added: 2 years ago
ESC 23 - We are joined onsite by Dr Mathieu Kerneis (Pitie Salpetriere APHP University Hospital, FR) and Dr Gilles Montalescot to discuss the findings from the ARAMIS trial (NCT03018834). ARAMIS was the largest randomised controlled trial of acute myocarditis. The study included 120 hospitalised, symptomatic patients with increased cardiac troponin and diagnosed acute myocarditis using cardiac… View more

Imaging & Diagnostics

MI/ACS
Job title: Interventional Cardiologist
Dr Mark Mariathas is an interventional cardiologist based at the Bristol Heart Institute, University Hospitals Bristol & Weston NHS Foundation Trust in the United Kingdom. He is recognised for his expertise in complex coronary intervention and invasive coronary physiology, contributing to both clinical practice and academic research in cardiovascular medicine.Dr Mariathas has been involved in a… View more
Evangelos Giannitsis
Job title: Assistant Professor of Medicine in Heidelberg
Dr. Giannitsis, an Assistant Professor of Medicine based in Heidelberg, holds a medical degree from the University of Homburg. He pursued advanced training in internal medicine and cardiology at Lübeck University Hospital in Germany. Additionally, he completed a Ph.D. in internal medicine before assuming his current role in 2002. Dr. Giannitsis's research is centered on cardiac biomarkers,… View more
TCT 24: The EVOLVED Trial
Author(s): Marc Dweck Added: 1 year ago
TCT Conference 2024 - Clinical outcomes of early intervention in patients with asymptomatic aortic stenosis (AS) did not impact the composite primary outcome of all cause mortality and unplanned AS related hospitalisation.Dr Marc Dweck (University of Edinburgh, Edinburgh, UK) joins us in this short interview filmed onsite at TCT Conference to discuss the findings from EVOLVED (NCT03094143;… View more

Imaging & Diagnostics

Intervention